Moleculin Biotech, Inc. — Director's Dealing 2016

Aug 9, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2016-06-02

Reporting Person: PICKER DONALD H (President and COO, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	468635	Direct
Common Stock	99000	Indirect
Common Stock	153000	Indirect
Common Stock	300000	Indirect

Footnotes

F1: IntertechBio Corp. holds 630,000 shares of Issuer common stock. The reporting person is a shareholder and control person of IntertechBio Corp. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by IntertechBio Corp.

F2: Houston Pharmaceuticals, Inc. holds 629,000 shares of Issuer common stock. The reporting person is a shareholder and control person of Houston Pharmaceuticals, Inc. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Houston Pharmaceuticals, Inc.

F3: Annamed, Inc. holds 629,000 shares of Issuer common stock. The reporting person is a shareholder and control person of Annamed, Inc. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Annamed, Inc.